Cannapharmarx Inc (CPMD)
0.014
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Cannapharmarx Total Liabilities (Quarterly): 23.90M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 23.90M |
September 30, 2023 | 25.79M |
June 30, 2023 | 25.47M |
March 31, 2023 | 23.48M |
December 31, 2022 | 23.68M |
September 30, 2022 | 20.41M |
June 30, 2022 | 20.47M |
March 31, 2022 | 20.20M |
December 31, 2021 | 13.04M |
September 30, 2021 | 13.33M |
June 30, 2021 | 15.24M |
March 31, 2021 | 15.64M |
December 31, 2020 | 17.55M |
September 30, 2020 | 14.99M |
June 30, 2020 | 13.31M |
March 31, 2020 | 12.05M |
December 31, 2019 | 11.16M |
September 30, 2019 | 9.856M |
June 30, 2019 | 9.282M |
March 31, 2019 | 8.765M |
December 31, 2018 | 10.38M |
September 30, 2018 | 1.924M |
June 30, 2018 | 0.997M |
March 31, 2018 | 0.9643M |
December 31, 2017 | 0.9643M |
Date | Value |
---|---|
September 30, 2017 | 0.9593M |
June 30, 2017 | 0.9593M |
March 31, 2017 | 0.9593M |
December 31, 2016 | 0.9593M |
September 30, 2016 | 0.9256M |
June 30, 2016 | 0.8994M |
March 31, 2016 | 0.8492M |
December 31, 2015 | 0.6966M |
September 30, 2015 | 0.528M |
June 30, 2015 | 0.6873M |
March 31, 2015 | 2.149M |
December 31, 2014 | 2.085M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.3177M |
December 31, 2013 | 0.292M |
September 30, 2013 | 0.2698M |
June 30, 2013 | 0.2446M |
March 31, 2013 | 0.2205M |
December 31, 2012 | 0.1977M |
September 30, 2012 | 0.1768M |
June 30, 2012 | 0.1535M |
March 31, 2012 | 0.1355M |
December 31, 2011 | 0.0996M |
September 30, 2011 | 0.0777M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.282M
Minimum
Jun 2019
25.79M
Maximum
Sep 2023
17.31M
Average
15.64M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.75M |
Shareholders Equity (Quarterly) | -12.15M |